| Application no. and date | 15820351.3 (espacenet) (Federated) (European Patent Register), 20151203 | | Patent/reg. no. and date | DK/EP 3226843, 20210526 | | Publication date | 20171011 | | Priority no. and date | EP 14196605, 20141205 | | EP pub. no. and date |
EP 3226843 20171011 | | Effective date | | | Applicant/owner | Aragon Pharmaceuticals, Inc., 10990 Wilshire Blvd. Suite 440
Los Angeles, CA 90024, US | | Applicant ref. no. | 1599234 | | Inventor | VERRECK, Geert, c/o Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse, BE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 9/14 (2006.01) , A61K 9/20 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | ANTICANCERSAMMENSÆTNINGER | | Int. application no. | US2015063671 | | Int. publication no. | WO2016090105 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
